Výsledky vyhledávání - "I. C. van Gelder"

Akademický článek

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Publikováno v: Российский кардиологический журнал, Vol 26, Iss 9 (2021)

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Externí odkaz: https://doaj.org/article/18162abfdc004f77ac8e81ede02bf608

Zobrazit plný text záznamu

Akademický článek

Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women.

Autor: J E Siland, B O Nguyen, R R de With, I C Van Gelder, P van der Harst, M Rienstra

Publikováno v: PLoS ONE, Vol 16, Iss 2, p e0246907 (2021)

AimsLimited causal evidence is available on the relationship between body mass index (BMI) and atrial fibrillation (AF) progression. Sex differences have been noted and may be relevant for AF progression. We investigated the association between the B

Externí odkaz: https://doaj.org/article/703f201cc46c48d09cf7ec4ee2c5eba8

Zobrazit plný text záznamu

Plný text ve formátu HTML

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort

Autor: C Van Deutekom, B Geelhoed, B C Van Munster, S J L Bakker, R T Gansevoort, I C Van Gelder, M Rienstra

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): The PREVEND study is supported by the Dutch Kidney Foundation and the Netherlands Heart Foundation. Background Atrial fibrillation (AF) is a condition that occurs i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b51ec9297a8698609bf0a078eafbcdb
https://doi.org/10.1093/europace/euad122.038

Zobrazit plný text záznamu

Brady- and tachyarrhythmias in paroxysmal atrial fibrillation: results from long-term continuous electrocardiographic monitoring in RACE V

Autor: M H J Park Frausing, M Van De Lande, A H Maass, B O Nguyen, M E W Hemels, R Tieleman, T Koldenhof, M De Melis, D Linz, U Schotten, V Weberndorfer, H J G M Crijns, I C Van Gelder, J C Nielsen, M Rienstra

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): The Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foundation, and grant support from M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::62594651f11c7bc45779f9f33f4e9619
https://doi.org/10.1093/europace/euad122.221

Zobrazit plný text záznamu

Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial

Autor: T Koldenhof, I C Van Gelder, H J G M Crijns, M Rienstra, R G Tieleman

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: None. Purpose To investigate whether there are differences between nondihydropyridine calcium channel blockers and beta blockers on heart rate in patients with paroxysmal and persistent atrial fibrill

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7c8d81b50d0b246055c1261ebfd5eae7
https://doi.org/10.1093/europace/euad122.073

Zobrazit plný text záznamu

Obesity, epicardial adipose tissue and left atrial cardiomyopathy in patients with heart failure with preserved ejection fraction: a cardiac MRI based study

Autor: M Lobeek, T M Gorter, V P M Van Empel, O C Manintveld, R G Tieleman, A H Maass, K Vernooy, B D Westenbrink, I C Van Gelder, D J Van Veldhuisen, M Rienstra

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): unrestricted grant from Abbott-Netherlands to the University Medical Center Groningen Introduction Atrial fibrillation (AF) and heart failure (HF) with preserv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29e8677528fd8d4a4b1deef69303605d
https://doi.org/10.1093/europace/euad122.003

Zobrazit plný text záznamu

Number of comorbidities is associated with symptom severity and arrhythmia progression in paroxysmal atrial fibrillation - Data from the RACE V study

Autor: M E Van De Lande, C Van Deutekom, B Geelhoed, L B O Nguyen, R G Tieleman, V Weberndorfer, H J G M Crijns, M E W Hemels, M De Melis, U Schotten, D Linz, I C Van Gelder, M Rienstra

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): We acknowledge the support from the Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1db42b0606b2935855311a539558136a
https://doi.org/10.1093/europace/euad122.027

Zobrazit plný text záznamu

Heart rate increase and inappropriate sinus tachycardia after cryoballoon pulmonary vein isolation for atrial fibrillation

Autor: Michiel Rienstra, Yuri Blaauw, Eng S. Tan, Ans C.P. Wiesfeld, C van Deutekom, Robert G. Tieleman, H F Groenveld, I. C. Van Gelder, Bart A. Mulder

Publikováno v: Netherlands Heart Journal, 68. Bohn, Stafleu, Van Loghum

Background Cryoballoon pulmonary vein isolation (PVI) is a common therapy for atrial fibrillation (AF). While moderately increased sinus rhythm heart rate (HR) after PVI has been observed, inappropriate sinus tachycardia (IST) is a rare phenomenon. W

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21689bf6a231cc9414f9aff2e4837a7b
https://doi.org/10.1007/s12471-021-01645-9

Zobrazit plný text záznamu

mHealth-based assessment of rate control during recurrent paroxysms after an emergency department visit for recent-onset atrial fibrillation: a subanalysis of the RACE 7 ACWAS trial

Autor: R Van Der Velden, N A H A Pluymaekers, E A M P Dudink, J G L M Luermans, J G Meeder, T Lenderink, J Widdershoven, J J J Bucx, M Rienstra, I C Van Gelder, H J G M Crijns, D Linz

Publikováno v: European Heart Journal. 43

Introduction Achieving adequate rate control is a mainstay in the treatment of atrial fibrillation (AF). In the Rate Control versus Electrical Cardioversion Trial 7 – Acute Cardioversion versus Wait and See (RACE 7 ACWAS) trial, an early cardiovers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::35332cdae372df9cc5934d18c4e93823
https://doi.org/10.1093/eurheartj/ehac544.418

Zobrazit plný text záznamu

Alleviation of AF related symptoms following acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm with flecainide acetate oral inhalation solution

Autor: A J Camm, H J G M Crijns, A Elvan, Y Tuininga, E Badings, A F M Kuijper, J S S G De Jong, M Lee, D Schellings, I C Van Gelder, J Ruskin, P Kowey, C Dufton, J Maupas, L Belardinelli

Publikováno v: European Heart Journal. 43

Introduction Pharmacological restoration of sinus rhythm (SR) in patients with symptomatic atrial fibrillation (AF) is expected to be accompanied by prompt alleviation of symptoms to avoid the need for electrical cardioversion (ECV) and/or hospitaliz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a4de5608873425e1b0145d590cb16c7
https://doi.org/10.1093/eurheartj/ehac544.434

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání